| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 228 |
| 1 | PREDNISONE | 45 |
| 2 | CYCLOPHOSPHAMIDE | 38 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 38 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 38 |
| 5 | DOXORUBICIN | 31 |
| 6 | PREDNISOLONE | 27 |
| 7 | PREDNISOLONE ORAL | 27 |
| 8 | PREDNISOLONE ORAL SOLUTION | 27 |
| 9 | BENDAMUSTINE HCL | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RABIES VIRUS IMMUNE GLOBULIN | 2 | 0.0312 |
| 1 | BENDAMUSTINE HCL | 20 | 0.0013 |
| 2 | RITUXIMAB | 228 | 0.0011 |
| 3 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 4 | BRODALUMAB | 1 | 0.0005 |
| 5 | REMDESIVIR | 6 | 0.0005 |
| 6 | DOXORUBICIN | 31 | 0.0003 |
| 7 | BARICITINIB | 1 | 0.0003 |
| 8 | AMISULPRIDE | 2 | 0.0003 |
| 9 | OBINUTUZUMAB | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 242 | 0.0008 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Alkylating Drug [EPC] | 39 | 0.0002 |
| 7 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |